AARP headquarters in Washington, DC (via Shutterstock)
August 18, 2023 01:37 PM EDTUpdated 06:08 PM
Pharma
FDA+

AARP, in am­i­cus brief, ar­gues that CMS ne­go­ti­at­ing drug prices is in the pub­lic in­ter­est

Lia DeGroot

The AARP on Fri­day filed an am­i­cus brief ask­ing a judge to up­hold the In­fla­tion Re­duc­tion Act, ar­gu­ing that stop­ping the drug price ne­go­ti­a­tion pro­gram …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Roche’s Parkin­son’s drug flunks sec­ond mid-stage tri­al

David Ep­stein gets $140M for Ot­ti­mo's bi­func­tion­al take on hot PD-1xVEGF field

Sang­amo strikes an­oth­er brain-tar­get­ing AAV part­ner­ship, this time with Astel­las

Bris­tol My­ers pays $100M up­front to col­lab­o­rate with Leqem­bi orig­i­na­tor in Alzheimer's

A service from the Financial Times